| scholarly article | Q13442814 |
| P50 | author | Wiebe Braam | Q58810820 |
| P2093 | author name string | M Smits | |
| L Curfs | |||
| R Didden | |||
| H Struijker Boudier | |||
| H Keijzer | |||
| P2860 | cites work | Specific Genetic Disorders and Autism: Clinical Contribution Towards their Identification | Q22252659 |
| Abnormal melatonin synthesis in autism spectrum disorders | Q24652560 | ||
| Role of microRNAs in plant and animal development | Q28188025 | ||
| Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disability | Q28386102 | ||
| Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders | Q33914514 | ||
| Melatonin for insomnia in children with autism spectrum disorders | Q34009306 | ||
| Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia | Q34574260 | ||
| Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis | Q34976753 | ||
| Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. | Q35015993 | ||
| The basic physiology and pathophysiology of melatonin | Q36008982 | ||
| Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing | Q36321854 | ||
| Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms | Q37157901 | ||
| Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2. | Q37378059 | ||
| Polymorphism of human cytochrome P450 enzymes and its clinical impact | Q37514326 | ||
| MicroRNA regulates the expression of human cytochrome P450 1B1. | Q40230494 | ||
| Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine | Q41593416 | ||
| Loss of response to melatonin treatment is associated with slow melatonin metabolism. | Q43006480 | ||
| Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study | Q43673155 | ||
| Does hepatic metabolism of melatonin affect the endogenous serum melatonin level in man? | Q44009657 | ||
| Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. | Q44623059 | ||
| Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. | Q45225955 | ||
| Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers | Q46094088 | ||
| Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial | Q46551145 | ||
| Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients | Q46581816 | ||
| Coffee, CYP1A2 genotype, and risk of myocardial infarction | Q46979784 | ||
| Automated genomic DNA extraction from saliva using the QIAxtractor. | Q54437721 | ||
| Effect of Caffeine Intake 12 or 24 Hours Prior to Melatonin Intake and CYP1A2*1F Polymorphism on CYP1A2 Phenotyping by Melatonin | Q58735005 | ||
| P433 | issue | 11 | |
| P921 | main subject | autism | Q38404 |
| melatonin | Q180912 | ||
| autism spectrum disorder | Q1436063 | ||
| P304 | page(s) | 993-1000 | |
| P577 | publication date | 2012-07-23 | |
| P1433 | published in | Journal of Intellectual Disability Research | Q15757812 |
| P1476 | title | CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder? | |
| P478 | volume | 57 |
| Q28661706 | Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives |
| Q47754936 | Characterizing Sleep in Adolescents and Adults with Autism Spectrum Disorders |
| Q36808178 | Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder |
| Q34430684 | Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay |
| Q60304311 | Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder |
| Q50418448 | Low maternal melatonin level increases autism spectrum disorder risk in children |
| Q35774172 | Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together? |
| Q28529749 | Precision medicine in circadian rhythm sleep–wake disorders: current state and future perspectives |
| Q92689513 | Preliminary evaluation of a novel nine-biomarker profile for the prediction of autism spectrum disorder |
| Q35571849 | Rapid onset of syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine in an elderly type 2 diabetic patient with painful diabetic neuropathy |
| Q38806294 | Sleep Complaints and the 24-h Melatonin Level in Individuals with Smith-Magenis Syndrome: Assessment for Effective Intervention. |
| Q41486105 | Sleep in Autism Spectrum Disorders |
Search more.